In this issue of JAMA Surgery, Joseph et al1 examine the outcomes in trauma patients after resuscitative endovascular balloon occlusion of the aorta (REBOA) placement using 2 years of the American College of Surgeons Trauma Quality Improvement Program (ACS-TQIP) data set. The results demonstrate that patients in a propensity-matched cohort (140 patients in the REBOA group and 280 patients in the no-REBOA group) who underwent REBOA had a higher 24-hour mortality rate, acute kidney injury rate, and amputation rate. Yet, there was no difference in mortality in the emergency department or mortality after 24 hours in the hospital. In addition, there were no differences in transfusion requirements or intensive care unit and hospital lengths of stay. There was also no difference in survival based on REBOA and the need for further angioembolization or exploratory laparotomy procedures. The authors conclude by stating there is a significant “need for a concerted effort to clearly define when and in which patient population REBOA has a benefit.”
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Upchurch GR, Smith RS. The Need to Better Define the Who, What, and Where of Resuscitative Endovascular Balloon Occlusion of the Aorta. JAMA Surg. 2019;154(6):508–509. doi:10.1001/jamasurg.2019.0101
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: